P071 Supporting extrapolation of indications for ABP 501, the first adalimumab biosimilar: focus on Crohn’s disease

Authors :: Heather Sweet
Helen J. McBride
Xuan-Yu Wang
Scott Kuhns
S Halder
W Reinisch
W Khan
Source :: Journal of Crohn's and Colitis. 13:S121-S121
Publication Year :: 2019
Publisher :: Oxford University Press (OUP), 2019.

Subjects :: medicine.medical_specialty
Focus (computing)
Crohn's disease
business.industry
Gastroenterology
medicine
Adalimumab
Biosimilar
General Medicine
Intensive care medicine
medicine.disease
business
medicine.drug

Full Text Access

Tools